These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6083786)

  • 21. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension].
    Andreassen AK; Madsen S; Kjekshus J; Simonsen S
    Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1220-3. PubMed ID: 11402748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled aerosolized iloprost in the evaluation of heart transplant candidates--experiences with 45 cases.
    Sablotzki A; Hentschel T; Hofmann S; Simm A; Mühling J; Czeslick E
    J Clin Anesth; 2006 Mar; 18(2):108-13. PubMed ID: 16563327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of inhaled iloprost during off-medication time in patients with pulmonary arterial hypertension.
    Mereles D; Ewert R; Lodziewski S; Borst MM; Benz A; Olschewski H; Grünig E
    Respiration; 2007; 74(5):498-502. PubMed ID: 17449958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
    J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of the prostacyclin analogue taprostene on cardiovascular, pulmonary and renal disturbances in endotoxin-shocked rabbits.
    Schneider J
    Eicosanoids; 1991; 4(2):99-105. PubMed ID: 1910868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possibilities for clinical use of prostacyclin in vascular disease.
    Poredos P
    Pflugers Arch; 2000; 440(5 Suppl):R137-8. PubMed ID: 11005643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute hemodynamic (systemic and renal) and humoral effects of three increasing doses of iloprost in essential hypertensives.
    Arzilli F; Giovannetti R; Lenzi M; Salvetti A
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):856-60. PubMed ID: 2480147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemodynamic changes induced by prostacyclin in man.
    Szczeklik J; Szczeklik A; Nizankowski R
    Br Heart J; 1980 Sep; 44(3):254-8. PubMed ID: 7000101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PGl2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency.
    Fujita T; Fuke Y; Satomura A; Hidaka M; Ohsawa I; Endo M; Komatsu K; Ohi H
    Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):223-7. PubMed ID: 11728176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological manipulation of peripheral resistance during distal vascular reconstruction.
    Smith FC; Shearman CP
    Vasa Suppl; 1992; 36():55-7. PubMed ID: 1382323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Extended storage preservation of swine kidneys to 72 hours using iloprost].
    Rebmann U; Langkopf B; Schabel I; Pauer HD; Heynemann H; Förster W
    Z Urol Nephrol; 1985 Nov; 78(11):611-7. PubMed ID: 2420095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifibrillatory action of the stable orally active prostacyclin analogues iloprost and ZK 96 480 in rats after coronary artery ligation.
    Müller B; Maass B; Stürzebecher S; Skuballa W
    Biomed Biochim Acta; 1984; 43(8-9):S175-8. PubMed ID: 6083785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic, hormonal, and renal effects of the prostacyclin analogue iloprost in conscious dogs with and without heart failure.
    Elsner D; Kromer EP; Riegger AJ
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):601-8. PubMed ID: 1706801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial ischemia induced by prostacyclin and iloprost.
    Bugiardini R; Galvani M; Ferrini D; Gridelli C; Tollemeto D; Mari L; Puddu P; Lenzi S
    Clin Pharmacol Ther; 1985 Jul; 38(1):101-8. PubMed ID: 2408809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet effects of intravenous iloprost in patients with peripheral arterial obliterative disease. A placebo-controlled dose-response study.
    Darius H; Hossmann V; Schrör K
    Klin Wochenschr; 1986 Jun; 64(12):545-51. PubMed ID: 2426514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of prostaglandins in arterial thrombosis pathology: survey of an ongoing experience].
    Duvivier A; David JL
    Rev Med Liege; 1984 May; 39(9):354-61. PubMed ID: 6203155
    [No Abstract]   [Full Text] [Related]  

  • 39. A randomized, double-blind, crossover comparison of iloprost with dextran in patients with peripheral arterial occlusive disease.
    Ylitalo P; Kaukinen S; Reinikainen P; Salenius JP; Vapaatalo H
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):197-204. PubMed ID: 1694831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical benefits of iloprost, a stable prostacyclin (PGI2) analog, in severe peripheral arterial disease (PAD).
    Oberender H; Krais T; Schäfer M; Belcher G
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():311-6. PubMed ID: 2473610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.